Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MREO |
---|---|---|
09:32 ET | 5975 | 3.57 |
09:34 ET | 6903 | 3.55 |
09:36 ET | 6800 | 3.55 |
09:38 ET | 9511 | 3.55 |
09:39 ET | 9900 | 3.58 |
09:43 ET | 2987 | 3.56 |
09:45 ET | 900 | 3.56 |
09:48 ET | 3600 | 3.57 |
09:50 ET | 2062 | 3.57 |
09:54 ET | 100 | 3.56 |
09:56 ET | 1103 | 3.565 |
10:01 ET | 7135 | 3.55 |
10:03 ET | 2100 | 3.555 |
10:06 ET | 3300 | 3.5703 |
10:08 ET | 1300 | 3.565 |
10:10 ET | 1243 | 3.565 |
10:12 ET | 100 | 3.565 |
10:14 ET | 3250 | 3.595 |
10:15 ET | 700 | 3.5992 |
10:19 ET | 600 | 3.595 |
10:21 ET | 1793 | 3.58 |
10:24 ET | 700 | 3.575 |
10:26 ET | 2236 | 3.58 |
10:28 ET | 1900 | 3.605 |
10:30 ET | 4129 | 3.61 |
10:32 ET | 300 | 3.62 |
10:33 ET | 1300 | 3.62 |
10:35 ET | 300 | 3.615 |
10:37 ET | 4110 | 3.595 |
10:39 ET | 300 | 3.59 |
10:42 ET | 3087 | 3.595 |
10:44 ET | 2242 | 3.605 |
10:48 ET | 100 | 3.6 |
10:50 ET | 1800 | 3.605 |
10:53 ET | 17121 | 3.5808 |
10:55 ET | 500 | 3.58 |
10:57 ET | 848 | 3.56 |
11:00 ET | 1500 | 3.56 |
11:02 ET | 25944 | 3.52 |
11:04 ET | 3126 | 3.52 |
11:06 ET | 100 | 3.53 |
11:08 ET | 9041 | 3.545 |
11:09 ET | 600 | 3.545 |
11:11 ET | 200 | 3.54 |
11:13 ET | 900 | 3.54 |
11:15 ET | 1770 | 3.54 |
11:20 ET | 885 | 3.535 |
11:22 ET | 4547 | 3.54 |
11:24 ET | 31350 | 3.545 |
11:26 ET | 700 | 3.549 |
11:27 ET | 3181 | 3.56 |
11:29 ET | 100 | 3.555 |
11:31 ET | 1746 | 3.565 |
11:33 ET | 957 | 3.565 |
11:36 ET | 400 | 3.57 |
11:38 ET | 2800 | 3.575 |
11:40 ET | 474 | 3.58 |
11:42 ET | 7899 | 3.575 |
11:44 ET | 5454 | 3.58 |
11:47 ET | 100 | 3.575 |
11:49 ET | 4609 | 3.585 |
11:51 ET | 2115 | 3.58 |
11:56 ET | 5525 | 3.5965 |
11:58 ET | 900 | 3.59 |
12:00 ET | 1260 | 3.5901 |
12:02 ET | 12244 | 3.59 |
12:03 ET | 100 | 3.59 |
12:05 ET | 400 | 3.59 |
12:07 ET | 1000 | 3.6 |
12:09 ET | 4435 | 3.615 |
12:12 ET | 200 | 3.61 |
12:14 ET | 717 | 3.61 |
12:16 ET | 600 | 3.61 |
12:18 ET | 250 | 3.6 |
12:20 ET | 600 | 3.6 |
12:21 ET | 400 | 3.605 |
12:23 ET | 200 | 3.605 |
12:25 ET | 4189 | 3.615 |
12:27 ET | 1070 | 3.615 |
12:30 ET | 500 | 3.6 |
12:32 ET | 1100 | 3.59 |
12:34 ET | 2252 | 3.6 |
12:36 ET | 100 | 3.6 |
12:39 ET | 3118 | 3.605 |
12:41 ET | 300 | 3.605 |
12:43 ET | 800 | 3.61 |
12:45 ET | 300 | 3.62 |
12:48 ET | 500 | 3.615 |
12:50 ET | 300 | 3.61 |
12:52 ET | 400 | 3.62 |
12:54 ET | 742 | 3.62 |
12:56 ET | 2126 | 3.63 |
12:57 ET | 726 | 3.625 |
12:59 ET | 5048 | 3.625 |
01:01 ET | 400 | 3.625 |
01:03 ET | 4742 | 3.63 |
01:06 ET | 4294 | 3.635 |
01:08 ET | 400 | 3.625 |
01:10 ET | 200 | 3.62 |
01:12 ET | 800 | 3.625 |
01:14 ET | 200 | 3.62 |
01:15 ET | 3126 | 3.63 |
01:17 ET | 300 | 3.63 |
01:19 ET | 4357 | 3.63 |
01:21 ET | 3030 | 3.64 |
01:24 ET | 400 | 3.6301 |
01:28 ET | 200 | 3.63 |
01:30 ET | 200 | 3.63 |
01:32 ET | 1300 | 3.625 |
01:33 ET | 11806 | 3.63 |
01:35 ET | 100 | 3.635 |
01:37 ET | 100 | 3.63 |
01:39 ET | 1504 | 3.63 |
01:42 ET | 2616 | 3.62 |
01:44 ET | 5364 | 3.635 |
01:46 ET | 300 | 3.635 |
01:48 ET | 100 | 3.6301 |
01:51 ET | 3457 | 3.62 |
01:53 ET | 552 | 3.62 |
01:55 ET | 643 | 3.6206 |
01:57 ET | 4244 | 3.635 |
02:00 ET | 1000 | 3.63 |
02:02 ET | 300 | 3.63 |
02:04 ET | 100 | 3.635 |
02:06 ET | 10239 | 3.63 |
02:08 ET | 100 | 3.63 |
02:09 ET | 8483 | 3.63 |
02:11 ET | 1000 | 3.64 |
02:13 ET | 318 | 3.635 |
02:15 ET | 100 | 3.63 |
02:18 ET | 7530 | 3.635 |
02:20 ET | 100 | 3.635 |
02:22 ET | 1910 | 3.635 |
02:24 ET | 400 | 3.63 |
02:26 ET | 5772 | 3.64 |
02:27 ET | 400 | 3.6301 |
02:29 ET | 2862 | 3.62 |
02:31 ET | 2363 | 3.62 |
02:33 ET | 21264 | 3.615 |
02:36 ET | 500 | 3.6144 |
02:40 ET | 900 | 3.61 |
02:42 ET | 8774 | 3.635 |
02:44 ET | 5234 | 3.625 |
02:45 ET | 200 | 3.625 |
02:49 ET | 3332 | 3.615 |
02:51 ET | 400 | 3.615 |
02:54 ET | 1782 | 3.61 |
02:56 ET | 700 | 3.61 |
02:58 ET | 800 | 3.61 |
03:00 ET | 200 | 3.61 |
03:02 ET | 7758 | 3.6 |
03:03 ET | 5142 | 3.63 |
03:05 ET | 8775 | 3.625 |
03:07 ET | 3421 | 3.635 |
03:09 ET | 11681 | 3.65 |
03:12 ET | 500 | 3.645 |
03:14 ET | 300 | 3.64 |
03:16 ET | 600 | 3.64 |
03:18 ET | 8054 | 3.645 |
03:20 ET | 1572 | 3.64 |
03:21 ET | 100 | 3.64 |
03:23 ET | 200 | 3.64 |
03:25 ET | 800 | 3.641 |
03:27 ET | 3436 | 3.64 |
03:30 ET | 1896 | 3.645 |
03:32 ET | 1024 | 3.645 |
03:34 ET | 7288 | 3.64 |
03:36 ET | 500 | 3.64 |
03:38 ET | 23847 | 3.63 |
03:39 ET | 1536 | 3.63 |
03:41 ET | 8127 | 3.6518 |
03:43 ET | 3435 | 3.655 |
03:45 ET | 4500 | 3.655 |
03:48 ET | 11180 | 3.645 |
03:50 ET | 5391 | 3.65 |
03:52 ET | 9750 | 3.65 |
03:54 ET | 6544 | 3.645 |
03:56 ET | 6785 | 3.65 |
03:57 ET | 19566 | 3.64 |
03:59 ET | 16805 | 3.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Mereo BioPharma Group PLC | 554.7M | -11.4x | --- |
Immunome Inc | 721.4M | -2.2x | --- |
AnaptysBio Inc | 676.1M | -4.0x | --- |
SS Innovations International Inc | 708.6M | -30.3x | --- |
Stoke Therapeutics Inc | 683.8M | -5.4x | --- |
Praxis Precision Medicines Inc | 689.8M | -2.5x | --- |
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $554.7M |
---|---|
Revenue (TTM) | $10.1M |
Shares Outstanding | 152.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $-0.32 |
Book Value | $0.45 |
P/E Ratio | -11.4x |
Price/Sales (TTM) | 54.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.